Skip to main content

AMERIPRISE FINANCIAL INC

Position in NBIX — Neurocrine Biosciences Inc

CIK 820027 MINNEAPOLIS, MN

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$67,455,225
-$15,611,341 QoQ
Shares Held
512,033
-12.6% QoQ
Ownership
0.509%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 77.780924276365.ToString("F0")% None 22.219075723635.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $745,649,307 across 34 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (9.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
512,033 $67,455,225

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $67,455,225 512,033
2025-12-31 $83,066,566 585,677
2025-09-30 $86,274,317 614,577
2025-06-30 $55,711,462 443,245
2025-03-31 $34,917,523 315,710
2024-12-31 $56,439,883 413,479
2024-09-30 $57,159,948 496,094
2024-06-30 $56,881,387 413,172
2024-03-31 $55,905,456 405,347
2023-12-31 $56,096,421 425,747
2023-09-30 $56,091,260 498,589
2023-06-30 $47,171,216 500,225
2023-03-31 $55,248,302 545,824
2022-12-31 $72,093,981 603,600
2022-09-30 $77,413,600 728,873
2022-06-30 $65,948,240 676,531
2022-03-31 $77,949,466 831,461
2021-12-31 $60,254,024 707,456
2021-09-30 $19,041,106 198,531
2021-06-30 $17,491,614 179,733
2021-03-31 $19,733,288 202,913
2020-12-31 $7,430,865 77,526
2020-09-30 $32,332,740 336,239
2020-06-30 $46,154,674 378,317
2020-03-31 $31,602,777 365,139